Navigation Links
PetPace and Orivet Announce Groundbreaking Canine Pregnancy Study

PetPace, the makers of a smart health-monitoring collar for pets, and Orivet, a leader in pet genetic testing, today announced the launch of a groundbreaking study to identify and eventually predict problems and complications affecting pregnant dogs. This study is an extension of another ongoing general study of pregnant dogs sponsored by PetPace and conducted by Dr. Smadar Tal, DVM, DACT, DECAR, a veterinarian specializing in reproduction.

The two companies are global leaders in their respective fields, delivering innovative technology that helps breeders, veterinarians and pet owners provide unprecedented levels of medical care for dogs and cats. The combination of genetic testing for personalized health risk analysis with remote, continuous monitoring of vital signs and behavior and real-time alerting and analytics, enables caretakers to provide outstanding medical care to pets.

Dystocia, the medical term for difficulty giving birth, affects upwards of 10% of pregnant dogs. Uterine Inertia is by far the most common cause of dystocia in dogs, accounting for over 70% of cases. Uterine Inertia involves absent or weak uterine contractions, and thus an inability to push the fetus through the birth canal. There are multiple factors involved with development of Uterine Inertia, but a genetic predisposition is suspected. Despite this, a genetic marker for Uterine Inertia in dogs has not yet been identified.

The aim of the joint PetPace/Orivet study is to identify genetic markers and biometric data patterns that indicate both risk and actual occurrence of Uterine Inertia in canine labor. This information will be used to develop tools for breeders, veterinarians and pet owners – enabling them to provide better dog pregnancy care and management, more effective risk assessment, earlier identification of Inertia during labor, faster medical intervention when necessary, and overall improved chances for a favorable outcome.

Previous tests to collect biometrics on pregnant dogs of various breeds show promising results as to the likelihood of identification of pregnancy and the timing of whelping. The current study may expand this capability by providing valuable information regarding the most common medical complication associated with whelping.

“Combining vitals, behavioral and phenotypic data with genetic testing and advanced analysis can help us eventually create a risk assessment and management tool for Uterine Inertia in dogs,” said Dr. Noam Pik, BVSc, BMVS, MBA, MACVS, the CEO of Orivet Genetic Pet Care. “Such a tool will be of great value to breeders and any caretakers of pregnant dogs,” he continued.

“This joint study is yet another example of how PetPace applies its core technology to specific medical conditions to improve our overall ability to detect and manage common and serious diseases,” added Dr. Asaf Dagan, DVM, Diplomate ABVP (Canine and Feline practice), and PetPace’s Chief Veterinarian.

About PetPace

PetPace was founded in 2012 to bring peace of mind to pet owners and prevent unnecessary pain and suffering for dogs and cats through improved pet health and quality of life. PetPace specializes in the remote monitoring of pet vital signs by utilizing advanced analytical methods and alerting models. The company’s low power, wireless collar is fitted with an array of sensors that report abnormal vital signs within established physiological and behavioral parameters. Once an abnormal sign or behavior is detected, a sophisticated cloud-based analytical engine evaluates the signs and if needed, sends an immediate alert regarding any suspected condition. This allows the owner or the vet to take preemptive action to protect the pet’s health. For more information about PetPace real-time pet health monitoring, visit

About Orivet

Orivet Genetic Pet Care is a leading personalized-medicine organization offering innovative health care solutions for veterinarians and pet owners. The organization was founded in 2010, on the premise that each pet is unique, with its own set of specific traits, behaviors, genetic health needs and inherent risks. Orivet works with veterinarians, pet owners and responsible pet breeders to provide practical, evidence-based platforms focused on identifying risk and improving clinical outcomes. Learn more at

About Dr. Smadar Tal

Dr. Smadar Tal graduated with honors from the Ontario Veterinary College, Canada, in 1992. After several years of working in private practice in Canada, she relocated back to Israel, where she eventually established, owned and managed a large, progressive and successful private small animal practice for 22 years. While in practice she pursued her passion and became a diplomate of the American College of Theriogenologists. She went on to become a diplomate of the European College of Veterinary Reproduction.

Her training and experience have provided her with extensive knowledge and clinical expertise on subjects ranging from the male and female reproductive systems, pregnancy, parturition and neonatology to general medicine and surgery.

At present, Dr. Tal heads the Theriogenology department at the Koret School of Veterinary Medicine, Hebrew University, Israel. There she is involved in clinical work, teaching DVM students, and conducting research.

Main research interests include biological and medical aspects of canine pregnancy and neonatology, and reproductive system as a diagnostic tool in working dogs.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related biology technology :

1. Trivedi Global, Inc. and Roland Piedad, Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical to Reduce Inflammation and Autoimmune Disorders
2. Trivedi Global, Inc. and Ariadne Afaganis Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical on Inflammatory and Autoimmune Disorders
3. Trivedi Global, Inc. and Eileen Meagher Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical on Anti-Aging and Overall Skin Health
4. Trivedi Global, Inc. and Dimitrius Anagnos Announce the Research Results of a Biofield Energy Treated Nutraceutical for Reducing Inflammatory and Autoimmune Disorders
5. Trivedi Global, Inc. and Mark Stutheit Announce Research Results of a Biofield Energy Treated Nutraceutical to Mitigate Inflammation and Autoimmune Disorders
6. The Freedom from Cancer Startup Challenge Announces Companies Advancing 100+ Cancer Inventions
7. SkylineDx Announces Prognostic Tool to be Used as Part of Major New Myeloma Clinical Trial
8. NanoValent Pharmaceuticals Announces Exclusive Global Licensing Agreement with Children’s Hospital Los Angeles and Completion of First Wave of Financing
9. Pittcon Announces 2018 Award Recipients for Outstanding Achievements in Analytical Chemistry and Applied Spectroscopy
10. Phase Genomics Announces Availability of Kit-based ProxiMeta™ Hi-C Metagenome Deconvolution
11. ‘Roadtrip Nation’ Announces the Premiere of ‘A Balanced Equation,’ a New Series Highlighting Women in STEM
Post Your Comments:
(Date:11/3/2018)... N.C. (PRWEB) , ... November 01, 2018 , ... Triangle ... by Inc. Magazine as one of the fastest-growing private companies in the United States, ... Inc. 5000 list ranks private companies based on percentage revenue growth over the previous ...
(Date:10/31/2018)... ... October 30, 2018 , ... Today, the National Corn Growers ... of this global competition is to find new and innovative uses of field corn. ... farmers produced 14.6 billion bushels of corn and are on pace to produce the ...
(Date:10/24/2018)... (PRWEB) , ... October 22, 2018 , ... ... for research scientists, clinicians, and medical experts from around the world, will host ... event will focus on best practices in testing, chromatography, centrifugation, as well as ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... and his associate, Dr. Michael Kang, are offering current and new patients the ... results thanks to the emerging, proven treatment technology known as Piezosurgery® . ...
Breaking Biology Technology:
(Date:10/26/2018)... , ... October 25, 2018 , ... uBiome, the leader ... the Department of Pathology and Laboratory Medicine at University of California Los Angeles (UCLA), ... around the world, Dr. Braun will bring to uBiome a deep expertise on the ...
(Date:10/24/2018)... ... October 23, 2018 , ... Mitotech S.A., a Luxembourg-based ... a U.S. Phase 3 clinical trial of SkQ1 compound in patients with moderate ... stress within the mitochondria. Visomitin, a topical ophthalmic formulation of this innovative ...
(Date:10/18/2018)... ... October 18, 2018 , ... Drug toxicity is a ... needs to be identified and mitigated. Failure to recognize such toxicities during the ... as well as a serious challenge to drug developers faced with an unforeseen drug ...
Breaking Biology News(10 mins):